• Welcome to Phoenix Rising!

    Created in 2008, Phoenix Rising is the largest and oldest forum dedicated to furthering the understanding of, and finding treatments for, complex chronic illnesses such as chronic fatigue syndrome (ME/CFS), fibromyalgia, long COVID, postural orthostatic tachycardia syndrome (POTS), mast cell activation syndrome (MCAS), and allied diseases.

    To become a member, simply click the Register button at the top right.

Coyne demolishes Per Fink's trial of CBT for medically unexplained symptoms

A.B.

Senior Member
Messages
3,780
Danish RCT of cognitive behavior therapy for whatever ails your physician about you

http://blogs.plos.org/mindthebrain/...y-for-whatever-ails-your-physician-about-you/

As usual Coyne is good at spotting problems:

A summary overview of what I found:
The RCT:
  • Was unblinded to patients, interventionists, and to the physicians continuing to provide routine care.
  • Had a grossly unmatched, inadequate control/comparison group that leads to any benefit from nonspecific (placebo) factors in the trial counting toward the estimated efficacy of the intervention.
  • Relied on subjective self-report measures for primary outcomes.
  • With such a familiar trio of design flaws, even an inert homeopathic treatment would be found effective, if it were provided with the same positive expectations and support as the CBT in this RCT. [This may seem a flippant comment that reflects on my credibility, not the study. But please keep reading to my detailed analysis where I back it up.]
  • The study showed an inexplicably high rate of deterioration in both treatment and control group. Apparent improvement in the treatment group might only reflect less deterioration than in the control group.
  • The study is focused on unvalidated psychiatric diagnoses being applied to patients with multiple somatic complaints, some of whom may not yet have a medical diagnosis, but most clearly had confirmed physical illnesses.
  • It’s not CBT that was evaluated, but a complex multicomponent intervention in which what was called CBT is embedded in a way that its contribution cannot be evaluated

The authors also switched outcomes years after the trial began.
 
Last edited:

A.B.

Senior Member
Messages
3,780
The authors had originally proposed a scoring consistent with a very large body of literature. Dropping the original scoring precludes any direct comparison with this body of research, including basic norms. They claim that they switched scoring because two key subscales were correlated in the opposite direction of what is reported in the larger literature. This is troubling indication that something has gone terribly wrong in authors’ recruitment of a sample. It should not be pushed under the rug.

This also sounded interesting to me, although I'm not sure I understand. @Woolie help please
 

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
There is an attribution issue with this commentary.

In his blog at:

http://blogs.plos.org/mindthebrain/...y-for-whatever-ails-your-physician-about-you/

under the heading "Detailed analysis" Prof Coyne has written:

Danish RCT of cognitive behavior therapy for whatever ails your physician about you

(...)

See for instance the work of Allen Frances M.D., who had been the chair of the American Psychiatric Association‘s Diagnostic and Statistical Manual (DSM-IV) Task Force. He became a harsh critic of its shortcomings and the failures of APA to correct coverage of functional somatic syndromes in the next DSM.

Mislabeling Medical Illness As Mental Disorder

Unless DSM-5 changes these incredibly over inclusive criteria, it will greatly increase the rates of diagnosis of mental disorders in the medically ill – whether they have established diseases (like diabetes, coronary disease or cancer) or have unexplained medical conditions that so far have presented with somatic symptoms of unclear etiology.

And:

The diagnosis of mental disorder will be based solely on the clinician’s subjective and fallible judgment that the patient’s life has become ‘subsumed’ with health concerns and preoccupations, or that the response to distressing somatic symptoms is ‘excessive’ or ‘disproportionate,’ or that the coping strategies to deal with the symptom are ‘maladaptive’.

And:

“These are inherently unreliable and untrustworthy judgments that will open the floodgates to the overdiagnosis of mental disorder and promote the missed diagnosis of medical disorder.

The DSM 5 Task force refused to adopt changes proposed by Dr. Frances.


Professor Coyne has presented these extracts from Allen Frances' December 8, 2012 Psychology Today blog as though they had been authored by Allen Frances.

This is not the case. It is quite clearly stated by Prof Frances at the beginning of his commentary that he is quoting at length from communications with me, Suzy Chapman of Dx Revision Watch.

Yet Professor Coyne has chosen not to attribute the quotes he reproduces to me.

Here is an extract from Coyne's source material taken from:

Mislabeling Medical Illness As Mental Disorder

Allen Frances MD, DSM 5 in Distress Blog at Psychology Today, December 8, 2012

(...)

UK health advocate, Suzy Chapman, has closely monitored every step in the development of DSM 5. Her website is the best available resource for finding just about everything you need to know about DSM 5 and ICD-11.

Ms Chapman sent me a troubling email that summarizes where DSM 5 has gone wrong and the many harmful consequences that will follow. More details are available at: 'Somatic Symptom Disorder could capture millions more under mental health diagnosis' (http://wp.me/pKrrB-29B )

Ms. Chapman writes, "...The DSM-5 Somatic Symptom Disorders Work Group is planning to eliminate several little used DSM-IV Somatoform Disorders and replace them instead with an extremely broad new category that is likely to be wildly overused ('Somatic Symptom Disorder' – SSD).

"A person will meet the criteria for SSD by reporting just one bodily symptom that is distressing and/or disruptive to daily life and having just one of the following three reactions to it that persist for at least six months: 1) 'disproportionate' thoughts about the seriousness of their symptom(s); or 2) a high level of anxiety about their health; or, 3) devoting excessive time and energy to symptoms or health concerns.

"Unless DSM-5 changes these incredibly over inclusive criteria, it will greatly increase the rates of diagnosis of mental disorders in the medically ill – whether they have established diseases (like diabetes, coronary disease or cancer) or have unexplained medical conditions that so far have presented with somatic symptoms of unclear etiology.

"The diagnosis of mental disorder will be based solely on the clinician's subjective and fallible judgment that the patient's life has become 'subsumed' with health concerns and preoccupations, or that the response to distressing somatic symptoms is 'excessive' or 'disproportionate,' or that the coping strategies to deal with the symptom are 'maladaptive'.

"These are inherently unreliable and untrustworthy judgments that will open the floodgates to the overdiagnosis of mental disorder and promote the missed diagnosis of medical disorder (...)"

Ms Chapman has provided a devastating and compelling critique. It is crucial that DSM 5 tighten its over-inclusive wording to prevent what could otherwise be the wholesale dismissal of real medical symptoms as psychiatric illness- leading to missed diagnoses, incorrect treatment, stigma, and patients understandably feeling greatly misunderstood etc.

At the end of Prof Coyne's blog, he writes:

"Special thanks to John Peters and to Skeptical Cat for their assistance with my writing this blog. However, I have sole responsibility for any excesses or distortions."

As the person who has amassed a considerable body of work on the DSM-5 proposals since 2009, run a website dedicated to DSM-5 and ICD-11 development, raised awareness in 2010, 2011 and 2012 of the DSM-5 Review and Comment periods, encouraged hundreds of submissions during these public comment exercises on the SSD proposals, worked with journalists and co-authored several papers around SSD, it is interesting to note that Professor Coyne has chosen not to correctly attribute to me texts he uses to illustrate his analysis.

I would take this up with Coyne via Twitter but I am amongst those whom he continues to keep blocked.

Instead, I shall be asking Allen Frances if he will request that Coyne make the necessary corrections.
 
Last edited:

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
The second link Coyne gives to an Allen Frances Psychology Today blog commentary is this one (one of a series of three we collaborated on for his Psychology Today blog around DSM-5 and SSD and to which I contributed content):

https://www.psychologytoday.com/blo...sm-5-refuses-correct-somatic-symptom-disorder

Bad News: DSM 5 Refuses to Correct Somatic Symptom Disorder
Medical illness will be mislabeled mental disorder
Jan 16, 2013


about which Coyne writes:

Leading Frances to apologize to patients:

My heart goes out to all those who will be mislabeled with this misbegotten diagnosis. And I regret and apologize for my failure to be more effective.


In order to reach that point in Allen Frances' blog, Coyne would have read:

Many of you will have read a previous blog prepared by Suzy Chapman and me that contained alarming information about the new DSM 5 diagnosis 'Somatic Symptom Disorder.'

(...)

Suzy Chapman is not surprised. For three years, she has been engaged in a determined effort to educate professionals and the public about the problems in DSM 5 and has been doing her best to help correct them. Her website provides the most complete documentation of everything related to DSM 5 and ICD 11. (http://dxrevisionwatch.com/ )

Ms Chapman writes: "Unfortunately, the DSM 5 invitation for comments from the field turned out to be no more than an empty public relations show. For the second stakeholder review of DSM 5 draft criteria, the SSD disorder section attracted more submissions than almost any other section. Yet still the Work Group barreled blindly on with suggestions that were roundly opposed as hurtful to the medically ill — shrugging off criticism from professionals and remaining completely unreceptive to advocacy organization and patient concern.

"For its third draft, rather than revise in favor of less inclusive criteria, the Work Group's response was to lower the threshold even further — reducing the requirement for 'at least two from the B type criteria' to just one — placing even more medical patients at risk of attracting an inappropriate mental health diagnosis."

"Many years ago, the late Thomas Szasz said: 'In the days of the Malleus, if the physician could find no evidence of natural illness, he was expected to find evidence of witchcraft: today, if he cannot diagnose organic illness, he is expected to diagnose mental illness.' DSM 5's loosely defined Somatic Symptom Disorder is Szasz worst fear come true."

Thank you Ms Chapman. I think Szasz' general critique of psychiatry was far too broad, but he certainly did hit the nail right on the head when it comes to DSM 5 and its cavalier treatment of the medically ill.

(...)


Extraordinary then, the extent to which Coyne has grayed me out or "disappeared" me from these two commentaries on DSM-5's SSD.
 
Last edited:

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
In response to Coyne's blog:

Experts weigh in on Suzanne O’Sullivan’s commentary on imaginary illness in The Lancet
April 30, 2016

https://jcoynester.wordpress.com/20...ommentary-on-imaginary-illness-in-the-lancet/

(in which he gave Edward Shorter a platform and promoted Shorter's book "From Paralysis To Fatigue" and promoted Shorter's blog) I submitted the following Comment on May 3:

In his comments, Prof Ronald Pies draws attention to Allen Frances’ concerns for DSM-5’s new Somatic symptom disorder (SSD) category.

For ease of reference, here is a list of papers and commentaries on SSD published by Allen Frances in collaboration with Suzy Chapman:

http://www.twitlonger.com/show/n_1soku2i


which is still displaying as:


"Your comment is awaiting moderation"
 

JohntheJack

Senior Member
Messages
198
Location
Swansea, UK
There is an attribution issue with this commentary.

In his blog at:

http://blogs.plos.org/mindthebrain/...y-for-whatever-ails-your-physician-about-you/

under the heading "Detailed analysis" Prof Coyne has written:




Professor Coyne has presented these extracts from Allen Frances' December 8, 2012 Psychology Today blog as though they had been authored by Allen Frances.

This is not the case. It is quite clearly stated by Prof Frances at the beginning of his commentary that he is quoting at length from communications with me, Suzy Chapman of Dx Revision Watch.

Yet Professor Coyne has chosen not to attribute the quotes he reproduces to me.

Here is an extract from Coyne's source material taken from:

Mislabeling Medical Illness As Mental Disorder

Allen Frances MD, DSM 5 in Distress Blog at Psychology Today, December 8, 2012



At the end of Prof Coyne's blog, he writes:

"Special thanks to John Peters and to Skeptical Cat for their assistance with my writing this blog. However, I have sole responsibility for any excesses or distortions."

As the person who has amassed a considerable body of work on the DSM-5 proposals since 2009, run a website dedicated to DSM-5 and ICD-11 development, raised awareness in 2010, 2011 and 2012 of the DSM-5 Review and Comment periods, encouraged hundreds of submissions during these public comment exercises on the SSD proposals, worked with journalists and co-authored several papers around SSD, it is interesting to note that Professor Coyne has chosen not to correctly attribute to me texts he uses to illustrate his analysis.

I would take this up with Coyne via Twitter but I am amongst those whom he continues to keep blocked.

Instead, I shall be asking Allen Frances if he will request that Coyne make the necessary corrections.

Perhaps you could contact Prof Coyne through the blog and point this out.
 

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
Since the Coyne PLOS blog discusses the Fink et al BDS construct and also touches on DSM-5's SSD, I thought I would collate four key documents in this thread for reference, now that they are all public domain.

(I may also open a new thread for this important issue.)


(1) Bodily distress disorder in ICD-11: problems and prospects
Oye Gureje, GM Reed, Sept 2016 Open access

http://onlinelibrary.wiley.com/doi/10.1002/wps.20353/pdf


This is the most recent report from the ICD-11 Somatic Distress and Dissociative Disorders Working Group (S3DWG), which, among other tasks, has been asked to propose revisions to the Somatoform disorders categories in ICD-10.

This external working group is chaired by Oye Gureje. Frances Creed* is a member. I have the names of a couple of other members but the full S3DWG membership list is not in the public domain.

The paper published in September describes the proposals for the "Bodily distress disorder" construct as defined and entered into the ICD-11 Beta draft.

It is an SSD-like construct and SSD has been inserted in the Beta draft under "Synonyms" to "BDD" - as you can see here:

http://apps.who.int/classifications/icd11/browse/f/en#/http://id.who.int/icd/entity/767044268
http://apps.who.int/classifications/icd11/browse/l-m/en#/http://id.who.int/icd/entity/767044268

There are three proposed severities: Mild; Moderate; Severe, and for each a Definition has been entered into the draft.

As defined by ICD-11 core version, "BDD" shares all the problems inherent in DSM-5's Somatic symptom disorder.

Furthermore, it proposes to use a term that is already being used in the field, interchangeably, for Fink et al's "BDS" construct, despite the fact that "BDS" is differently conceptualized, has different criteria and potentially captures different (though to an extent overlapping) patient groups.

The divergence between the "BDS" construct and the "SSD" construct has been acknowledged by DSM-5's Dimsdale and by Fink, Creed and Henningsen.

*Although Francis Creed was a member of the DSM-5 work group, he does not like the SSD construct or the name. He favours the BDS construct, although he is on the ICD-11 working group that is proposing an SSD-like construct. So it doesn't surprise if Creed is holding out for the term "Bodily distress disorder" as it is already often used for Fink's BDS.

The PCCG group also proposes to use the term "Bodily Distress Disorders" but as a section header under which the categories "Bodily Stress Syndrome" and "Health anxiety" (which replaces "Hypochondriasis") would sit.


----------------------------------

(2) An alternative construct has been proposed by the (external) Primary Care Consultation Group (PCCG) for use in the ICD-11 PHC.

The ICD-11 PHC is being developed in parallel with the core ICD-11 and is an abridged version of the Mental disorders chapter for use in Primary Care and low resource settings. It is expected to comprise 28 of the "most common" mental health disorders found in Primary Care.

The PCCG is chaired by Prof Sir David Goldberg; the membership list is in the public domain.

The PCCG's most recent paper is:

Multiple somatic symptoms in primary care: A field study for ICD-11 PHC: WHO's revised classification of mental disorders in primary care settings
David P. Goldberg, D.M., Geoffrey M. Reed, Ph.D. et al

https://www.researchgate.net/profile/Geoffrey_Reed/publication/308959165_Multiple_somatic_symptoms_in_primary_care_A_field_study_for_ICD-11_PHC_WHO%27s_revised_classification_of_mental_disorders_in_primary_care_settings/links/581f399f08aea429b298d6f2.pdf

The Primary Care Consultation Group proposes to call its recommended construct "Bodily Stress Syndrome" (BSS), which, as already noted, would sit under a section heading, "Bodily Distress Disorders."

Their initial proposed construct had been for a close adaptation of Fink et al's (2010) Bodily distress syndrome (BDS).

From the most recent paper:

"...The ICD-10 PHC [1] contained a category called ‘medically unexplained somatic complaints’, defined by negative physical investigations and frequent visits to the PCP despite these negative findings. The development of the ICD-11 PHC provided an opportunity to re-think this description, drawing in part on research conducted in Denmark by Fink and colleagues [7,8], including a recommendation that three or more symptoms was a useful threshold for primary care populations [9].Fink and his colleagues proposed a conceptualization of Bodily Distress Syndrome that emphasized the co-occurrence of symptoms falling into cardiopulmonary, musculoskeletal, and gastrointestinal clusters and explicitly linking these symptom clusters to ‘functional’ syndromes of non-cardiac chest pain, fibromyalgia, and irritable bowel syndrome. This conceptualization was subsequently expanded to include an additional cluster of ‘general’ symptoms (e.g., concentration difficulties,memory impairment, fatigue) theorized as corresponding to chronic fatigue syndrome [7,9]. Support for the notion that apparently distinct collections of somatic symptoms are united by underlying common features has been provided by a number of empirical studies [10–19]."
The most recent paper states:

"As a concept, BSS brings together under a common rubric allegedly
different patterns of symptoms variously described as constituting
different ‘functional’ syndromes (e.g., fibromyalgia, irritable bowel syndrome)."​

Within the proposed criteria for the Primary Care Consultation Group's proposed "BSS", there is no listing of "Chronic fatigue syndrome" under "Exclusion" or "Differential diagnosis", see Page 86-87 Appendix 2 [1].


The original proposed "BSS" criteria, based on symptom clusters from body systems, and closely adapted from Fink et al (2012) and are set out in Appendix 2 (Pages 86-87) of the Lam et al paper in reference [1] at the end of this report.

In the most recent paper it says:

"The version of the Bodily Stress Syndrome diagnosis used in this
study was adapted for use in primary care settings from the proposed
diagnosis of Bodily Distress Disorder proposed for the main ICD-11
[24] by creating a specific cutoff of at least three symptoms not explained
by no known medical pathology that were associated with distress
or impairment and eliminating the requirement that the PCP make
a judgment about whether the attention devoted to the symptoms is
‘excessive’. Patients with fewer than three symptoms are very common
in primary care setting. Our focus group study [6] had indicated that
PCPs preferred a specific symptom cutoff point and were reluctant to
make a judgment about the subjective degree of attention paid by the
patient to the symptoms."​

and

"One purpose of the present study was to examine the importance of
the specific symptoms clusters emphasized by Fink and colleagues
based on work in Denmark [7,8,9]. While clusters of cardiopulmonary,
musculoskeletal, gastrointestinal, and ‘general’ symptoms can be identified
in the current data, in the current clinical sample their significance
for diagnosing BSS is less clear given that the most common symptom
pattern was three or more symptoms in multiple clusters (57.9%;
CI95% = 53.8–62.0) and the average number of somatic symptoms
among this groupwasmore than 15, and nearly 11 in the overall sample
(see Table 3). Only in China was single symptom cluster BSS the most
common pattern (44.4%; CI95%=32.0–56.8). Therefore, for the ICD-11
PHC description of BSS, the best course would seem to be to describe
these common patterns but not to require that symptom presentations
conform to them in assigning a diagnosis."​


No psychobehavioural responses are required to meet the Fink "BDS" criteria. But for "BSS" there is a nod, potentially, towards BDD's and SSD's requirement for psychobehavioural responses.

Note that like SSD, the core version's proposed "BDD" can be applied to any symptom(s) - if the clinician decides the response to the symptom(s) is "excessive". So that means BDD, like SSD, could be applied as an additional diagnosis to diagnosed cancer patients, coronary heart disease patients, patients with MS, diabetes, CFS, ME, IBS, FM etc.

Whereas in the PCCG's "BSS" (in common with Fink's "BDS") - "If the symptoms are accounted for by a known physical disease this is not BSS." [1]


ICD Revision expects there to be construct/disorder congruency between the disorders to be included in the Primary Care version and the corresponding disorders in the Core version and all this has been discussed with ICD Revision's, Dr Geoffrey Reed.

Some time ago, I requested Exclusions for PVFS, BME and CFS under "BDD". Dr Reed has said that he cannot request Exclusions until the missing G93.3 legacy terms have been restored to the Beta draft, "but at such time, he would be happy to do so."

Note: The recommendations of external work groups are advisory and approval of proposals is the responsibility of the Joint Task Force (JTF) and the ICD classification experts.

ICD's Robert Jakob gave assurances, last June, that he can be “crystal clear” that there is no proposal or intention to classify the ICD-10 G93.3 legacy terms under the Mental and behavioural disorders chapter.



Think of it as a continuum, with the "pure" Fink BDS on the far left, and the "pure" DSM-5 SSD on the far right:

Operationalised BDS ---- proposed BSS ---- proposed BDD ---- published SSD


Add to that the fact of the S3DWG's proposing to call its construct by the same name that is often seen used in the literature and in the field for "BDS" and you don't need me to spell out the scope for disorder creep and the potential difficulty for maintaining construct integrity within and beyond ICD-11; nor the implications for all patients.

For an expansion on this see my document below (which was written before the two new papers were published):

Comment submitted to TAG Mental Health in May re: Bodily distress disorder (May 2015)

https://dxrevisionwatch.files.wordpress.com/2015/06/chapman-bdd-submission-may-2015.pdf

----------------------------------

(3) Here is the 2013 MASTER PROTOCOL for the ICD-11 PHC field trials:

MASTER PROTOCOL Depression, Anxiety and Somatic Symptoms in Global PC Settings: A Field Study for the ICD-11-PHC

http://www.psychiatryresearchtrust.co.uk/protocols/WorldHealth14.pdf


In the Lam et al (2013) paper, below, there is also discussion of the pilot field trials that took place in 2011 and the characterization and criteria, as were proposed in 2012, are set out in Appendix 2.

1 Full free: Proposed new diagnoses of anxious depression and bodily stress syndrome in ICD-11-PHC: an international focus group study, Lam et al (2013)

http://fampra.oxfordjournals.org/content/30/1/76.full.pdf html

[Edited to add extracts and other comment]
 
Last edited:

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
Note that in the ICD-11 Beta draft, IBS remains under

http://apps.who.int/classifications/icd11/browse/f/en#/http://id.who.int/icd/entity/1158238623

Chapter: Diseases of the digestive system
> Irritable bowel syndrome or certain specified functional bowel disorders
>> Functional gastrointestinal disorders
>>> Irritable bowel syndrome



For ICD-11 Beta draft the most recent proposal for Fibromyalgia is to relocate under a new Chronic pain class:

http://apps.who.int/classifications/icd11/browse/f/en#/http://id.who.int/icd/entity/236601102

Chapter: Symptoms, signs or clinical findings, not elsewhere classified

General symptoms, signs or clinical findings
Pain
> Chronic pain
>> Chronic primary pain
>>> Mono-site primary chronic pains syndromes
>>> Multi-site primary chronic pains syndromes
>Fibromyalgia​
 
Last edited:

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
In his PLOS blog, Coyne has written:

....The chair of The DSM Somatic Symptom Disorder work group has delivered a scathing critique of the very concept of medically unexplained symptoms.

Dimsdale JE. Medically unexplained symptoms: a treacherous foundation for somatoform disorders?. Psychiatric Clinics of North America. 2011 Sep 30;34(3):511-3.

Dimsdale noted that applying this psychiatric diagnosis sidesteps the quality of medical examination that led up to it. Furthermore:

Many illnesses present initially with nonspecific signs such as fatigue, long before the disease progresses to the point where laboratory and physical findings can establish a diagnosis.
And such diagnoses may encompass far too varied a group of patients for any intervention to make sense:

One needs to acknowledge that diseases are very heterogeneous. That heterogeneity may account for the variance in response to intervention. Histologically, similar tumors have different surface receptors, which affect response to chemotherapy. Particularly in chronic disease presentations such as irritable bowel syndrome or chronic fatigue syndrome, the heterogeneity of the illness makes it perilous to diagnose all such patients as having MUS and an underlying somatoform disorder.
A reminder that Dimsdale signed off on the new DSM-5 SSD criteria.

He also refused to budge on a redraft of the criteria to tighten them up and reduce over diagnosis. It wasn't just the Task Force that rejected Allen Frances' redraft suggestions; they had also been rejected by Dimsdale.


At the APA's Annual Conference in Philadelphia, in 2012, Dimsdale gave a slide presentation on the unpublished field trials for what, at that point, was proposed to be called "CSSD". (The new diagnosis for DSM-5 was subsequently named "SSD.")

At the end of his presentation, Dr Dimsdale took a number of questions from the audience around proposals for CSSD and Conversion disorder.

One questioner asked: Chronic fatigue syndrome has not been a part of the DSM-IV so far. Would there be any place for that in the DSM-5?

Dr Dimsdale's response was: That's an important question. Chronic fatigue is an important, distressing, disabling condition - it is remarkably heterogeneous...remarkably heterogeneous. We feel that some patients with chronic fatigue would meet the criteria for CSSD - some wouldn't.

The questioner responded: And what would be the cut off point...or what would be the criteria to include some and exclude others?

Dr Dimsdale replied: Well, chronic fatigue is really almost a poster child for medically unexplained symptoms as a diagnosis - it's a very, very heterogeneous disorder and we would say that the B type criteria are defining. Now, I have friends with chronic fatigue - some of them would meet these criteria and some wouldn't - so if a person is unable to put this down or unable to get beyond the...who is just stuck with the B type considerations, we would consider that to be having CSSD.


For testing the reliability of the proposed criteria for what was then known as "CSSD", Dimsdale reported that three groups had been studied for the field trials:

488 healthy people;

205 people with cancer and malignancy (some patients in this group were said to have severe coronary disease);

94 people in a "functional somatic" group (said to include "irritable bowel" and "chronic widespread pain");

Dr Dimsdale reported:

that about 15% of the cancer and malignancy group met CSSD criteria if "one of the B type criteria" was required; if the threshold was increased to "two B type criteria" about 10% would meet the criteria for dual-diagnosis of cancer + "Somatic Symptom Disorder."

For the 94 "functional somatic" study group, about 26% would be coded if one "B type" cognition was required; 13% were coded if two cognitions were required.

About 7% of the "healthy" group were caught by the CSSD criteria.


When the final draft for the DSM-5 was released, the proposed name for the new diagnosis had been changed from "CSSD" to "SDD".

The number of "B type" criteria required to meet the diagnosis had also been changed - reduced from a requirement for two from the "B type" psychobehavioural responses to symptoms, to just one.

For its third draft, rather than revise in favour of less inclusive criteria, Dimsdale's work group had lowered the threshold for a diagnosis of SSD, despite the considerable concerns expressed in stakeholders' submissions in the first and second review periods.


I have still not been credited for the extracts from my text used by Coyne in his PLOS blog.
 
Last edited:

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
Extracts from:

Submission from Suzy Chapman in the Third DSM-5 Comment and Review exercise (May 2 – June 15 2012)


https://dxrevisionwatch.files.wordpress.com/2012/06/scdsm5sub7.pdf

(...)

The SSD Work Group's framework "...will allow a diagnosis of somatic symptom disorder in
addition to a general medical condition, whether the latter is a well-recognized organic
disease or a functional somatic syndrome such as irritable bowel syndrome or chronic fatigue
syndrome."


"...These disorders typically present first in non-psychiatric settings and somatic symptom
disorders can accompany diverse general medical as well as psychiatric diagnoses. Having
somatic symptoms of unclear etiology is not in itself sufficient to make this diagnosis. Some
patients, for instance with irritable bowel syndrome or fibromyalgia would not necessarily
qualify for a somatic symptom disorder diagnosis. Conversely, having somatic symptoms of an
established disorder (e.g. diabetes) does not exclude these diagnoses if the criteria are
otherwise met."
[1]

[1] Justification of Criteria - Somatic Symptoms, May 4, 2011 for second DSM-5 stakeholder
review.

(...)

During the Q & A session at the end of Dr Dimsdale's APA Conference presentation, a
questioner raised the issue that practitioners who are not clinicians or psychiatric
professionals might have some difficulty interpreting the wording of the B type criteria to
differentiate between negative and positive coping strategies.

Dr Dimsdale was asked to expand on how the B type criteria would be operationalized and
by what means patients with chronic medical conditions who devote time and energy to
health care strategies to try to improve their symptoms and their level of functioning
would be evaluated in the field by a very wide range of DSM users and differentiated from
patients considered to be spending "excessive time and energy devoted to symptoms or
health concerns"
or perceived as having become "absorbed" by their illness and whose
preoccupations were felt to be "disproportionate."

By what means will the practitioner reliably assess an individual's response to illness
within the social context of the patient's life and determine what should be coded as
"excessive preoccupation" or indicate that this patient's life has become "subsumed" or
"overwhelmed" by concerns about illness and "devotion" to symptoms?

By what means would a practitioner determine how much of a patient's time spent
"searching the internet looking for data" (to quote an example provided by Dr Dimsdale)
might be considered a reasonable response to chronic health concerns within the context
of this patient's experience?

I am not reassured from Dr Dimsdale's responses that these B (1), (2) and (3) criteria can
be safely applied outside the optimal conditions of field trials, in settings where
practitioners may not necessarily have the time nor instruction for administration of
diagnostic assessment tools, and where decisions to code or not to code may hang on
arbitrary and subjective perceptions.

(...)

In his journal article Medically Unexplained Symptoms: A Treacherous Foundation for
Somatoform Disorders?
[2] Dr Dimsdale discusses the unreliability of "medically
unexplained" as a concept and acknowledges the perils of missed and misdiagnosis:

"...On the face of it, MUS sounds affectively neutral but the term sidesteps the quality of the
medical evaluation itself. A number of factors influence the accuracy of diagnoses. Most
prominently, one must consider how thorough was the physician’s evaluation of the patient.
How adequate was the physician’s knowledge base in synthesizing the information obtained
from the history and physical examination? The time pressures in primary care make it
difficult to comprehensively evaluate patients and thus contribute to delays and slips in
diagnosis. Similarly, physicians can wear blinders or have tunnel vision in evaluating
patients.1 Just because a patient has previously had MUS is no guarantee that the patient has
yet another MUS. As a result of these factors, the reliability of the diagnosis of MUS is
notoriously low..."


For DSM-5 then, the Work Group proposes to deemphasize "medically unexplained" as the
central defining feature of this disorder group and instead, shift the focus to the patient’s
cognitions – "excessive thoughts, behaviors and feelings" about the seriousness of
distressing and persistent somatic symptoms which may or may not accompany diagnosed
general medical conditions – and the extent to which "illness preoccupation" is perceived to
have come to dominate the patient’s life.

Dr Dimsdale concludes:

"Patients present with an admixture of symptoms, preconceptions, feelings, and illnesses. The
task of psychiatric diagnosis is to attend to the patient’s thoughts, feelings, and behaviors
that are determining his/her response to symptoms, be they explained or unexplained."


In proposing to license the application of an additional mental health diagnosis for all
illnesses if the clinician considers the patient also meets the criteria for a "bolt-on"
diagnosis of SSD, Dr Dimsdale and colleagues appear hell bent on stumbling blindly from
the "treacherous foundation" of the "somatoform disorders" into the quicksands of
unvalidated constructs and highly subjective, difficult to measure criteria.

(...)

Dr Dimsdale concedes his committee has struggled from the outset with these B type
criteria but feels its proposals are "a step in the right direction."

Patients deserve better than this; science demands rigor.

In the absence of a substantial body of independent evidence for the SSD construct
as a reliable, valid and safe alternative, I urge the Work Group not to proceed with its
proposals for the reorganization of the "Somatoform Disorders" categories in favour
of the status quo, or to dispense altogether with this section of DSM. There can be no
justification for replacing one set of dysfunctional, unreliable and unsafe categories
with another.



[2] Dimsdale JE. Medically Unexplained Symptoms: A Treacherous Foundation for Somatoform Disorders? Psychiatr Clin N Am 34 (2011) 511–513 doi:10.1016/j.psc.2011.05.003
 

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
I'll stand corrected, but I can't recall Coyne expressing opinion on the DSM-5 proposals for SSD, either during the three review and comment periods, in 2010, 2011 and 2012, or since.

Are his views on the final SSD characterization and criteria (for which a similar construct is proposed for ICD-11) posted anywhere? I'd be interested to know his position on SSD.
 

Dx Revision Watch

Suzy Chapman Owner of Dx Revision Watch
Messages
3,061
Location
UK
From Coyne's blog:

I tried making sense of a table of the additional diagnoses that the patients in this study had been given. A considerable proportion of patients had physical conditions that would not be considered psychiatric problems in the United States.

(...)

In the United States, many patients and specialists would consider considering irritable bowel syndrome as a psychiatric condition offensive and counterproductive....


Always the fault of those damn Brits, eh?

Walitt, anyone?
 
Messages
1,446
.
@Dx Revision Watch wrote:
'll stand corrected, but I can't recall Coyne expressing opinion on the DSM-5 proposals for SSD, either during the three review and comment periods, in 2010, 2011 and 2012, or since.'


Coyne has definitely supported and vociferously promoted both Brian Walitt's and Edward Shorter's psychosomatic constructs of ME though. It looks like Coyne doesn't know if he's coming or going.

Coyne still hasn't corrected the misattribution of quotes in his latest Blog either, despite having been informed that Allen Francis was not the author of the quotes which Coyne used (and has been informed that the author of the Quotes which Coyne used was in fact Suzy Chapman/Dx Revision Watch).

That's shoddy.

I wonder if Coyne has some particular reason to avoid correctly attributing the quotes to Suzy Chapman, because until he does he is currently adding insult to injury.
.
 
Last edited:

Woolie

Senior Member
Messages
3,263
This also sounded interesting to me, although I'm not sure I understand. @Woolie help please
I just had a look, @A.B.

The SF36 is a self-report questionnaire with eight different subscales e.g., mental health, physical functioning, vitality etc. You can add up all the subscales that relate to physical health (vitality, physical functioning, bodily pain, physical role functioning etc) and come up with what called a Physical Component Summary (PCS).

These authors were going to use this PCS as their primary outcome measure, but changed their minds and went with another outcome measure: something they call an "aggregate measure", which includes just three physical subscales: physical functioning, bodily pain and vitality.

They decided to use their own 3-subscale aggregate measure instead of the standard PCS (all physical subscale scores) for some weird reasons. They say:
We found an unexpected moderate negative correlation of the physical and mental component summary measures, which are constructed as independent measures. According to the SF-36 manual, a low or zero correlation of the physical and mental components is a prerequisite of their use. 23
This makes no sense, as it applies only to large normative samples. It perfectly possible for physical and mental component summary measures to be negatively correlated in a small clinical sample.

They also say:
Moreover, three SF-36 scales that contribute considerably to the PCS did not fulfil basic scaling assumptions.
This is weird too, as the patients were a highly selected bunch, so you would expect certain scores to be clustered up one of the ends of the scale, not nicely evenly distributed like in a normative population.

However, weirdly, its not clear to me that they did this switching to improve their results. Both alternative measures seemed to be equally good at yielding the results they wanted.
 
Last edited: